Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale
Susanne Singer(Jagiellonian University), Christian Simon(University of Lausanne), Monica Pinto(Jagiellonian University), Amy Fullerton(Jacksonville University), Hisham Mehanna(University of Birmingham), Juan Ignacio Arrarás, Joaquim Castro Silva(Instituto Português de Oncologia Francisco Gentil), Sanja Krejović-Trivić(University of Belgrade), Bente Brokstad Herlofson(Oslo University Hospital), Alexander Fabian(University Hospital Schleswig-Holstein), Noam Yarom(Tel Aviv University), Iwona M. Tomaszewska(Jagiellonian University), Naomi Kiyota(Kobe University Hospital), Allen C. Sherman(Winthrop Rockefeller Foundation), Loreto Fernández‐González(Fundación Arturo López Pérez), Ourania Nicolatou‐Galitis(National and Kapodistrian University of Athens), Lisa Licitra(University of Milan), Dina Salem(Ain Shams University), Pierluigi Bonomo(Azienda Ospedaliero-Universitaria Careggi), Kristin Bjordal(University of Oslo), Eva Hammerlid(Sahlgrenska University Hospital), Ingo Baumann(Heidelberg University), Judith E. Raber‐Durlacher(Academic Center for Dentistry Amsterdam), Andreas Boehm(Klinikum St. Georg), Cecilie Delphin Amdal(Oslo University Hospital), Christine Brannan(Mount Vernon Cancer Centre), Johanna Inhestern, Razvan Galalae(MedAustron), Wei‐Chu Chie(National Taiwan University), Kathy Taylor(Johannes Gutenberg University Mainz), M.A. Santos
Cited by 17
Related Papers
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study.
|Journal of Clinical Oncology|1996|1.2k
The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care
|European Journal of Cancer|2005|687